Skip to main content
Log in

Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Solid organ transplantation (SOT) is a lifesaving procedure for those with end-stage kidney, liver, heart, lung, and intestinal diseases, including females of childbearing age who wish to proceed with pregnancy following transplantation. While there is clear risk associated with use of mycophenolate during pregnancy, the risks associated with use of other immunosuppressant agents are less well understood, and the timing of use in pregnancy may be pertinent when considering the risk versus benefit for individual patients. In addition to overall fetal outcomes, including gestational age, birth weight, and mortality, this review summarizes published literature on additional complications that have been examined in association with maternal use during pregnancy and postpartum while breastfeeding. Compared with non-transplant pregnancies, pregnancies in transplant recipients are associated with lower birth weight and earlier gestational age. Effects associated with particular immunosuppressant agents in the infant include renal dysfunction from calcineurin inhibitors, myelosuppression from azathioprine, and decreased circulating immune cells with several agents. However, these effects are noted to primarily be transient, though the decrease in immune cells may predispose the infant to increased infectious complications in the first year of life. Utilizing relative infant dose estimations, nearly all commonly utilized immunosuppressants are likely safe during breastfeeding given the limited exposure to the infant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. U.S. Department of Health & Human Sciences. Organ procurement and transplantation network. https://optn.transplant.hrsa.gov/data/.

  2. Transplant Pregnancy Registry International (TPRI) 2020 annual report. Philadelphia: Gift of Life Institute; 2021.

  3. Testa G, Koon EC, Johannesson L, McKenna GJ, Anthony T, Klintmalm GB, et al. Living donor uterus transplantation: a single center’s observations and lessons learned from early setbacks to technical success. Am J Transplant. 2017;17(11):2901–10.

    Article  CAS  PubMed  Google Scholar 

  4. McKay DB, Josephson MA. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5:1592–9.

    Article  PubMed  Google Scholar 

  5. Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol. 2007;36(2):412–9.

    Article  PubMed  Google Scholar 

  6. Cunningham FG, Cox SM, Harstad TW, Mason RA, Pritchard JA. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol. 1990;163(2):453–9.

    Article  CAS  PubMed  Google Scholar 

  7. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ. 1997;315:279–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43(8):487–514.

    Article  CAS  PubMed  Google Scholar 

  9. Newton ER, Hale TW. Drugs in breast milk. Clin Obstet Gynecol. 2015;58(4):868–84.

    Article  PubMed  Google Scholar 

  10. Hart A, Lentine KL, Smith JM, Miller JM, Skeans MA, Prentice M, et al. OPTN/SRTR 2019 annual data report: kidney. Am J Transplant. 2021;21(Suppl 2):21–137.

    Article  PubMed  Google Scholar 

  11. Kwong AJ, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21(Suppl 2):208–315.

    Article  PubMed  Google Scholar 

  12. Kandaswamy R, Stock PG, Miller J, Skeans MA, White J, Wainright J, et al. OPTN/SRTR 2019 annual data report: pancreas. Am J Transplant. 2021;21(Suppl 2):138–207.

    Article  PubMed  Google Scholar 

  13. Colvin M, Smith JM, Ahn Y, Skeans MA, Messick E, Goff R, et al. OPTN/SRTR 2019 annual data report: heart. Am J Transplant. 2021;21(Suppl 2):356–440.

    Article  PubMed  Google Scholar 

  14. Valapour M, Lehr CJ, Skeans MA, Smith JM, Miller E, Goff R, et al. OPTN/SRTR 2019 annual data report: lung. Am J Transplant. 2021;21(Suppl 2):441–520.

    Article  PubMed  Google Scholar 

  15. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Eleventh. Philadelphia: Wolters Kluwer; 2017.

    Google Scholar 

  16. Brännström M, Johannesson L, Bokström H, Kvarnstrom N, Molne J, Dahm-Kahler P, et al. Livebirth after uterus transplantation. Lancet. 2015;385(9968):607–16.

    Article  PubMed  Google Scholar 

  17. Ejzenberg D, Andraus W, BaratelliCarelliMendes LR, Ducatti L, Song A, et al. Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility. Lancet. 2019;392(10165):2697–704.

    Article  PubMed  Google Scholar 

  18. Brucker SY, Strowitzki T, Taran FA, Rall K, Schöller D, Hoopmann M, et al. Living-donor uterus transplantation: pre-, intra-, and postoperative parameters relevant to surgical success, pregnancy, and obstetrics with live births. J Clin Med. 2020;9(8):2485.

    Article  PubMed Central  Google Scholar 

  19. Wiles K, Chappell L, Clark K, Elman L, Hall M, Lightstone L, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019;20(1):401.

    Article  PubMed  PubMed Central  Google Scholar 

  20. DeFilippis EM, Haythe J, Farr MA, Kobashigawa J, Kittleson MM. Practice patterns surrounding pregnancy after heart transplantation. Circ Heart Fail. 2020;13(4): e006811.

    Article  PubMed  Google Scholar 

  21. Christopher V, Al-Chalabi T, Richardson PD, Muiesan P, Rela M, Heaton ND, et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl. 2006;12(7):1138–43.

    Article  PubMed  Google Scholar 

  22. Perales-Puchalt A, Vila Vives JM, López Montes J, Diago Almela VJ, Perales A. Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison. J Matern Fetal Neonatal Med. 2012;25(8):1363–6.

    Article  CAS  PubMed  Google Scholar 

  23. Sifontis NM, Coscia LA, Moritz MJ, Daller JA, Armenti VT. Pregnancy outcomes in liver transplant recipients on Neoral® versus tacrolimus based therapy. Am J Transplant. 2007;S2:1264A.

    Google Scholar 

  24. Khan SS, Constantinescu S, Silva P, Coscia LA, Armenti VT. Pregnancy outcomes in renal transplant recipients on Neoral vs tacrolimus. J Am Soc Nephrol. 2006;17:562A.

    Google Scholar 

  25. Prograf (tacrolimus) [prescribing information]. Northbrook: Astellas Pharma US, Inc.; 2021.

  26. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997;64(4):559–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G. Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment. Nephrol Dial Transplant. 1997;12(12):2764–5.

    Article  CAS  PubMed  Google Scholar 

  28. Zheng S, Easterling TR, Hays K, Umans JG, Miodovnik M, Clark S, et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol. 2013;76(6):988–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hutson JR, Garcia-Bournissen F, Davis A, Koren G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther. 2011;90(1):67–76.

    Article  CAS  PubMed  Google Scholar 

  30. Gil S, Saura R, Forestier F, Farinotti R. P-glycoprotein expression of the human placenta during pregnancy. Placenta. 2005;26(2–3):268–70.

    Article  CAS  PubMed  Google Scholar 

  31. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000;70(12):1718–21.

    Article  CAS  PubMed  Google Scholar 

  32. Jain AB, Reyes J, Marcos A, Mazariegos G, Eghtesad B, Fontes PA, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center’s experience update at 13 years. Transplantation. 2003;76(5):827–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Jain AB, Shapiro R, Scantlebury VP, Potdar S, Jordan ML, Flohr J, et al. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center’s experience. Transplantation. 2004;77(6):897–902.

    Article  PubMed  Google Scholar 

  34. Dinelli M, Ono E, Viana P, dos Santos A, Moraes-Pinto M. Growth of children born to renal transplanted women. Eur J Pediatr. 2017;176:1201–7.

    Article  PubMed  Google Scholar 

  35. Bachmann F, Budde K, Gerland M, Wiechers C, Heyne N, Nadalin S, et al. Pregnancy following kidney transplantation—impact on mother and graft function and focus on childrens’ longitudinal development. BMC Pregnancy Childbirth. 2019;19(1):376.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Schreiber-Zamora J, Szpotanska-Sikorska M, Drozdowska-Szymczak A, Czaplinska N, Pietrzak B, Wielgos M, Kociszewska-Najman B. Neurological development of children born to mothers after kidney transplantation. J Matern Fetal Neonatal Med. 2019;32(9):1523–7.

    Article  PubMed  Google Scholar 

  37. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776–89.

    Article  Google Scholar 

  38. Aktürk S, Sadioğlu RE, Şengül Ş, Keven K. Acute kidney injury in an infant of a kidney allograft recipient. Clin Kidney J. 2019;13(1):123–4.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Feyaerts D, Gillard J, van Cranenbroek B, Rigodanzo Marins L, Baghdady MMS, Comitini G, et al. Maternal, decidual, and neonatal lymphocyte composition is affected in pregnant kidney transplant recipients. Front Immunol. 2021;12: 735564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Ono E, Dos Santos AM, Viana PO, Dinelli MI, Sass N, De Oliveira L, et al. Immunophenotypic profile and increased risk of hospital admission for infection in infants born to female kidney transplant recipients. Am J Transplant. 2015;15(6):1654–65.

    Article  CAS  PubMed  Google Scholar 

  41. Drozdowska-Szymczak A, Pietrzak B, Czaplińska N, Schreiber-Zamora J, Jabiry-Zieniewicz Z, Wielgoś M, et al. Immunological status of children born to female liver recipients. Ann Transplant. 2018;23:182–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Dinelli MIS, Ono E, Viana PO, Spina FG, Weckx LY, Dos Santos AMN, et al. Response to immunization in children born to renal transplant recipients using immunosuppressive drugs during gestation. Vaccine. 2016;34(4):404–7.

    Article  CAS  PubMed  Google Scholar 

  43. Gow PJ, Ghabrial H, Smallwood RA, Morgan DJ, Ching MS. Neonatal hepatic drug elimination. Pharmacol Toxicol. 2001;88(1):3–15.

    Article  CAS  PubMed  Google Scholar 

  44. Bramham K, Chusney G, Lee J, Lightstone L, Nelson-Piercy C. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol. 2013;8(4):563–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Kociszewska-Najman B, Mazanowska N, Pietrzak B, et al. Low transfer of tacrolimus and its metabolites into colostrum of graft recipient mothers. Nutrients. 2018;10(3):267.

    Article  PubMed Central  CAS  Google Scholar 

  46. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–41.

    Article  Google Scholar 

  47. French AE, Soldin SJ, Soldin OP, Koren G. Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother. 2003;37(6):815–8.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Gardiner SJ, Begg EJ. Breastfeeding during tacrolimus therapy. Obstet Gynecol. 2006;107:453–5.

    Article  PubMed  Google Scholar 

  49. Hiramatsu Y, Yoshida S, Kotani T, Nakamura E, Kimura Y, Fujita D, et al. Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus. Lupus. 2018;27(14):2245–52.

    Article  CAS  PubMed  Google Scholar 

  50. Gomez-Lobo V, Landy HJ, Matsumoto C, Fishbein TM. Pregnancy in an intestinal transplant recipient. Obstet Gynecol. 2012;120(2 Pt 2):497–500.

    Article  PubMed  Google Scholar 

  51. Klintmalm GB, Gunby RT Jr. Successful pregnancy in a liver transplant recipient on belatacept. Liver Transpl. 2020;26(9):1193–4.

    Article  PubMed  Google Scholar 

  52. Akamine Y, Fujiyama N, Kagaya H, Saito M, Miura H, Terada Y, et al. Tacrolimus concentrations after renal transplantation in a mother-neonate dyad: maternal, neonatal and breast milk measurements. J Clin Pharm Ther. 2021;46(6):1800–3.

    Article  CAS  PubMed  Google Scholar 

  53. Gouraud A, Bernard N, Millaret A, Bruel M, Paret N, Descotes J, Vial T. Follow-up of tacrolimus breastfed babies. Transplantation. 2012;94(6):e38-40.

    Article  PubMed  Google Scholar 

  54. Constantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014;28(8):1163–73.

    Article  PubMed  Google Scholar 

  55. Lewis GJ, Lamont CA, Lee HA, Slapak M. Successful pregnancy in a renal transplant recipient taking cyclosporin A. Br Med J (Clin Res Ed). 1983;286(6365):603.

    Article  CAS  Google Scholar 

  56. Burrows DA, O’Neil TJ, Sorrells TL. Successful twin pregnancy after renal transplant maintained on cyclosporine A immunosuppression. Obstet Gynecol. 1988;72(3 Pt 2):459–61.

    CAS  PubMed  Google Scholar 

  57. Löwenstein BR, Vain NW, Perrone SV, Wright DR, Boullón FJ, Favaloro RG. Successful pregnancy and vaginal delivery after heart transplantation. Am J Obstet Gynecol. 1988;158(3 Pt 1):589–90.

    Article  PubMed  Google Scholar 

  58. Venkataramanan R, Koneru B, Wang CC, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby. Transplantation. 1988;46(3):468–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Ceccaldi PF, Gavard L, Mandelbrot L, Rey E, Farinotti R, Treluyer JM, Gil S. Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model. Obstet Gynecol Int. 2009;2009: 726593.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Lamarque V, Leleu MF, Monka C, Krupp P. Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmune. Transplant Proc. 1997;29(5):2480.

    Article  CAS  PubMed  Google Scholar 

  61. Willis FR, Findlay CA, Gorrie MJ, Watson MA, Wilkinson AG, Beattie TJ. Children of renal transplant recipient mothers. J Paediatr Child Health. 2000;36(3):230–5.

    Article  CAS  PubMed  Google Scholar 

  62. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051–5.

    Article  CAS  PubMed  Google Scholar 

  63. Nulman I, Sgro M, Barrera M, Chitayat D, Cairney J, Koren G. Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant. Paediatr Drugs. 2010;12(2):113–22.

    Article  PubMed  Google Scholar 

  64. Schreiber-Zamora J, Szpotanska-Sikorska M, Drozdowska-Szymczak A, Czaplinska N, Pietrzak B, Wielgos M, et al. Neurological development of children born to mothers after kidney transplantation. J Matern Fetal Neonatal Med. 2019;32(9):1523–7.

    Article  PubMed  Google Scholar 

  65. Stanley CW, Gottlieb R, Zager R, Eisenberg J, Richmond R, Moritz MJ, et al. Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. Transplant Proc. 1999;31(1–2):241–2.

    Article  CAS  PubMed  Google Scholar 

  66. Giudice PL, Dubourg L, Hadj-Aïssa A, Saïd MH, Claris O, Audra P, et al. Renal function of children exposed to cyclosporin in utero. Nephrol Dial Transplant. 2000;15(10):1575–9.

    Article  CAS  PubMed  Google Scholar 

  67. Al-Khader AA, Basri N, Al-Ghamdi, Shaheen, Hejaili, Flaiw, Qureshi J. Pregnancies in renal transplant recipients—with a focus on babies. Ann Transplant. 2004;9(3):65–7.

  68. Shaheen FA, Al-Sulaiman MH, Al-Khader AA. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation. 1993;56(1):224–5.

    Article  CAS  PubMed  Google Scholar 

  69. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation. 1994;57(1):133–44.

    Article  CAS  PubMed  Google Scholar 

  70. Rose ML, Dominguez M, Leaver N, Lachno R, Yacoub MH. Analysis of T cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients. Transplantation. 1989;48(2):223–6.

    Article  CAS  PubMed  Google Scholar 

  71. Di Paolo S, Schena A, Morrone LF, Manfredi G, Stallone G, Derosa C, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation. 2000;69(10):2049–54.

    Article  PubMed  Google Scholar 

  72. Dinelli MIS, Dos Santos AMN, Weckx LY, de Moraes-Pinto MI. Safe administration of rotavirus vaccine in a cohort of infants exposed to immunosuppressive drugs during gestation. Transpl Infect Dis. 2018;20(5): e12951.

    Article  PubMed  CAS  Google Scholar 

  73. Miniero R, Tardivo I, Curtoni ES, Segoloni GP, La Rocca E, Nino A, et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol. 2002;15(6):626–32.

    PubMed  Google Scholar 

  74. Nyberg G, Haljamäe U, Frisenette-Fich C, Wennergren M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation. 1998;65(2):253–5.

    Article  CAS  PubMed  Google Scholar 

  75. Moretti ME, Sgro M, Johnson DW, Sauve RS, Woolgar MJ, Taddio A, et al. Cyclosporine excretion into breast milk. Transplantation. 2003;75(12):2144–6.

    Article  CAS  PubMed  Google Scholar 

  76. Thiru Y, Bateman DN, Coulthard MG. Successful breast feeding while mother was taking cyclosporin. BMJ. 1997;315(7106):463.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Muñoz-Flores-Thiagarajan KD, Easterling T, Davis C, et al. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol. 2001;97:816–8.

    PubMed  Google Scholar 

  78. Osadchy A, Koren G. Cyclosporine and lactation: when the mother is willing to breastfeed. Ther Drug Monit. 2011;33:147–8.

    Article  PubMed  Google Scholar 

  79. Thiagarajan KM, Arakali SR, Mealey KJ, Cardonick EH, Gaughan WJ, Davison JM, et al. Safety considerations: breastfeeding after transplant. Prog Transplant. 2013;23(2):137–46.

    Article  PubMed  Google Scholar 

  80. Kociszewska-Najman B, Mazanowska N, Borek-Dzięcioł B, Pączek L, Samborowska E, Szpotańska-Sikorska M, et al. Low content of cyclosporine A and its metabolites in the colostrum of post-transplant mothers. Nutrients. 2020;12(9):2713.

    Article  CAS  PubMed Central  Google Scholar 

  81. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002;17(2):121–30.

    Article  PubMed  Google Scholar 

  82. Hale TW, Rowe HE. Medications and mothers’ milk. 17th ed. New York: Springer Publishing Company; 2017.

    Google Scholar 

  83. Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, et al. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut. 2014;63(3):451–7.

    Article  CAS  PubMed  Google Scholar 

  84. Prévot A, Martini S, Guignard JP. In utero exposure to immunosuppressive drugs. Biol Neonate. 2002;81(2):73–81.

    Article  PubMed  Google Scholar 

  85. Flanagan E, Wright EK, Hardikar W, Sparrow MP, Connell WR, Kamm MA, et al. Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates. Aliment Pharmacol Ther. 2021;53(7):810–20.

    CAS  PubMed  Google Scholar 

  86. Wang M. Iron deficiency and other types of anemia in infants and children. Am Fam Physician. 2016;93(4):270–8.

    PubMed  Google Scholar 

  87. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol. 2006;62(4):453–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother. 2006;40(12):2269–72.

    Article  CAS  PubMed  Google Scholar 

  89. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG. 2007;114(4):498–501.

    Article  CAS  PubMed  Google Scholar 

  90. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28(10):1209–13.

    Article  CAS  PubMed  Google Scholar 

  91. Angelberger S, Reinisch W, Messerschmidt A, et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5(2):95–100.

    Article  PubMed  Google Scholar 

  92. Chu SH, Liu KL, Chiang YJ, Wang HH, Lai PC. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc. 2008;40:2446–8.

    Article  CAS  PubMed  Google Scholar 

  93. Guarfia O, Rial Mdel C, Casadei D. Pregnancy under sirolimus-based immunosuppression. Transplantation. 2006;81(4):646.

    Google Scholar 

  94. Framarino dei Malatesta M, Corona LE, De Luca L, et al. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Transplantation. 2011;91(9):e69-71.

    Article  PubMed  Google Scholar 

  95. Jankowska I, Oldakowska-Jedynak U, Zieniewica J, et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant Proc. 2004;36(1):3232–3.

    Article  CAS  PubMed  Google Scholar 

  96. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82(12):1698–702.

    Article  CAS  PubMed  Google Scholar 

  97. Rapamune (sirolimus) [prescribing information]. Philadelphia: Wyeth Pharmaceuticals Inc; 2012.

  98. Fiocchi R, D’Elia E, Vittori C, Sebastiani R, Strobelt N, Eleftheriou G, et al. First report of a successful pregnancy in an everolimus-treated heart-transplant patient: neonatal disappearance of immunosuppressive drugs. Am J Transplant. 2016;16:1319–22.

    Article  CAS  PubMed  Google Scholar 

  99. Ciortea R, Ciobanu L, Matei E, Zanafi C, Blaga LD. Pregnancy in a liver transplant patient treated with everolimus and tacrolimus. J Gastrointestin Liver Dis. 2020;29(4):685–6.

    Article  PubMed  Google Scholar 

  100. Carta P, Caroti L, Zanazzi M. Pregnancy in a kidney transplant patient treated with everolimus. Am J Kidney Dis. 2012;60(2):329.

    Article  PubMed  Google Scholar 

  101. Carta P, Zanazzi M, Minetti EE. Unplanned pregnancies in kidney transplanted patients treated with everolimus: three case reports. Transpl Int. 2015;28:370–2.

    Article  CAS  PubMed  Google Scholar 

  102. Veroux M, Corona D, Veroux P. Pregnancy under everolimus-based immunosuppression. Transpl Int. 2011;24(12):e115–7.

    Article  CAS  PubMed  Google Scholar 

  103. Margoles HR, Gomez-Lobo V, Veis JH, Sherman MJ, Moore J Jr. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report. Transplant Proc. 2014;46(1):281–3.

    Article  CAS  PubMed  Google Scholar 

  104. Zortress (everolimus) [prescribing information]. East Hanover: Novartis Pharmaceuticals Corp.; 2018.

  105. Kociszewska-Najman B, Szpotańska-Sikorska M, Mazanowska N, Pączek L, Samborowska E, Dadlez M, et al. Transfer of everolimus into colostrum of a kidney transplant mother. Ann Transplant. 2017;22:755–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Coscia L, Constantinescu S, Davison J, Moritz M, Armenti V. Immunosuppressive drugs and fetal outcome. Best Pract Res Clin Obstet Gynecol. 2014;28(8):1174–87.

    Article  Google Scholar 

  107. Shah S, Verma P. Overview of pregnancy in renal transplant patients. Int J Nephrol. 2016;2016:1–7.

    Article  CAS  Google Scholar 

  108. Cowan SW, Davison JM, Doria C, Moritz MJ, Armenti VT. Pregnancy after cardiac transplantation. Cardiol Clin. 2012;30(3):441–52.

    Article  PubMed  Google Scholar 

  109. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science. 1978;202(4366):436–8.

    Article  CAS  PubMed  Google Scholar 

  110. Cai E, Czuzoj-Shulman N, Abenhaim HA. Maternal and fetal outcomes in pregnancies with long-term corticosteroid use. J Matern Fetal Neonatal Med. 2021;34(11):1797–804.

    Article  CAS  PubMed  Google Scholar 

  111. Ince-Askan H, van den Akker ELT, de Rijke YB, van Rossum EFC, Hazes JMW, Dolhain RJEM. Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study. RMD Open. 2019;5: e000852.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Nørgård B, Pedersen L, Christensen LA, Sørensen HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007;102(7):1406–13.

    Article  PubMed  CAS  Google Scholar 

  113. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30:2127–32.

    PubMed  Google Scholar 

  114. Ryu RJ, Easterling TR, Caritis SN, Venkataramana R, Umans JG, Ahmed MS, Clark S, Kantrowitz-Gordon I, Hays K, Bennett B, Honaker MT, Thummel KE, Shen DD, Hebert MF. Prednisone pharmacokinetics during pregnancy and lactation. J Clin Pharmacol. 2018;58:1223–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Drugs and Lactation Database (LactMed) [Internet]. Bethesda: National Library of Medicine (US); 2006. Prednisone. [Updated 2021 Aug 16].

  116. Henderson JJ, Hartmann PE, Newnham JP, et al. Effect of preterm birth and antenatal corticosteroid treatment on lactogenesis II in women. Pediatrics. 2008;121:e92-100.

    Article  PubMed  Google Scholar 

  117. Nulojix (belatacept) [prescribing information]. Princeton: Bristol-Myers Squibb Company; 2021.

  118. CellCept (mycophenolate mofetil) [prescribing information]. San Francisco: Genentech USA, Inc; 2018.

  119. Myfortic (mycophenolic acid) [prescribing information]. East Hanover: Novartis Pharmaceuticals; 2020.

  120. King RW, Baca MJ, Armenti VT, Kaplan B. Pregnancy outcomes related to mycophenolate exposure in female kidney transplant recipients. Am J Transplant. 2017;17(1):151–60.

    Article  CAS  PubMed  Google Scholar 

  121. National Vital Statistics System – Birth Data. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/nvss/births.htm.

  122. Data and Statistics on Birth Defects. Centers for Disease Control and Prevention. https://www.cdc.gov/ncbddd/birthdefects/data.html.

  123. Neoral (cyclosporine, modified) [prescribing information]. East Hanover: Novartis Pharmaceuticals Corporation; 2009.

  124. Anderson PO, Sauberan JB. Modeling drug passage into human milk. Clin Pharmacol Ther. 2016;100(1):42–52.

    Article  CAS  PubMed  Google Scholar 

  125. Behrens O, Kohlhaw K, Günter H, Wonigeit K, Niesert S. Nachweis von Cyclosporin A in der Muttermilch—ist Stillen kontraindiziert? [Detection of cyclosporin A in breast milk—is breast feeding contraindicated?]. Geburtshilfe Frauenheilkd. 1989;49(2):207–9 (German).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina T. Doligalski.

Ethics declarations

Funding

Not applicable.

Conflict of interest

None.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Code availability

Not applicable.

Author contributions

All authors contributed to literature review, manuscript creation, and manuscript editing. CM, JC, and CD additionally contributed to article outline and peer review revisions.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McKinzie, C.J., Casale, J.P., Guerci, J.C. et al. Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients. Pediatr Drugs 24, 483–497 (2022). https://doi.org/10.1007/s40272-022-00525-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-022-00525-y

Navigation